HWH. Shaw Warren

H. Shaw Warren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


H. Shaw Warren has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Judith Hellman

    Department of Anesthesia and Critical Care, Massachusetts General Hospital , Boston

    3 shared publications
  • Guangjie Sun

    Infectious Disease Unit, Massachusetts General Hospital , Boston

    2 shared publications
  • Tian Lin

    Infectious Disease Unit, Massachusetts General Hospital, Boston, MA 02129, USA

    2 shared publications
  • Xueya Liang

    Infectious Disease Unit, Massachusetts General Hospital , Boston

    2 shared publications
  • Aranya Bagchi

    Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, USA

    1 shared publication
  • Barbara G. Paton

    Microbiology Laboratory, Massachusetts Eye and Ear Infirmary, Boston

    1 shared publication

Latest Publications

  • Open Access

    Editorial: Control issues in sepsis: what modulates apoptosis?

    by H. Shaw Warren

    Vaki et al. propose that there may be factor(s) in the serum of patients with severe sepsis that modulate apoptosis of lymphocytes and monocytes.


  • Open Access

    Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll‐Like Receptor Agonists and Is Blocked by Hemopexin

    by Tian Lin, Young Ho Kwak, Fatima Sammy, Ping He, Sujatha Thundivalappil, Guangjie Sun, Wei Chao, H. Shaw Warren

    Detection of microbial components by immune cells via Toll-like receptors (TLRs) with subsequent induction of inflammation is essential for host defe


  • Open Access

    Resilience to Bacterial Infection: Difference between Species Could Be Due to Proteins in Serum

    by H. Shaw Warren, Catherine Fitting, Eva Hoff, Minou Adib‐Conquy, Laura Beasley‐Topliffe, Brenda Tesini, Xueya Liang, Catherine Valentine, Judith Hellman, Douglas Hayden, et al.

    Vertebrates vary in resistance and resilience to infectious diseases, and the mechanisms that regulate the tradeoff between these often opposing prot


  • Open Access

    Editorial: Mouse models to study sepsis syndrome in humans

    by H. Shaw Warren

    Journal of Leukocyte Biology considers manuscripts of original investigations focusing on the origins, developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes, and other cells involved in host defense. These include full-length papers on original research, rapid communications of new discoveries, letters, commentaries, and invited reviews.


  • Open Access

    Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages

    by Xueya Liang, Tian Lin, Guangjie Sun, Laura Beasley-Topliffe, Jean-Marc Cavaillon, H. Shaw Warren

    The heme-binding protein hemopexin limits TLR4 and TLR2 agonist-induced macrophage cytokine production through a mechanism distinct from heme oxygenase-1. Detection of LPS in tissues is an integral component of innate immunity that acts to protect against invasion by Gram-negative bacteria. Plasma down-regulates LPS-induced cytokine production from macrophages, thereby limiting systemic inflammation in blood and distant tissues. To identify the protein(s) involved in this process, we used classical biochemical chromatographic techniques to identify fractions of mouse sera that suppress LPS-induced TNF from bone marrow-derived macrophages (BMDMs). Fractionation yielded microgram quantities of a protein that was identified by MS to be hemopexin (Hx). Mouse Hx purified on hemin-agarose beads and rhHx decreased the production of cytokines from BMDMs and peritoneal macrophages induced by LPS. Preincubation of LPS with Hx did not affect the activity of LPS on LAL, whereas preincubation of Hx with macrophages followed by washing resulted in decreased activity of these cells in response to LPS, suggesting that Hx acts on macrophages rather than LPS. Heme-free Hx did not stimulate HO-1 in the macrophages. Purified Hx also decreased TNF and IL-6 from macrophages induced by the synthetic TLR2 agonist Pam3Cys. Our data suggest that Hx, which is an acute-phase protein that increases during inflammation, limits TLR4 and TLR2 agonist-induced macrophage cytokine production directly through a mechanism distinct from HO-1.


  • Open Access

    A Genomic Score Prognostic of Outcome in Trauma Patients

    by The Inflammation and the Host Response to Injury Large Scale Collaborative Research Program, H. Shaw Warren, Constance M. Elson, Douglas L. Hayden, David A. Schoenfeld, J. Perren Cobb, Ronald V. Maier, Lyle L. Moldawer, Ernest E. Moore, Brian G. Harbrecht, et al.

    Traumatic injuries frequently lead to infection, organ failure, and death. Health care providers rely on several injury scoring systems to quantify the extent of injury and to help predict clinical outcome. Physiological, anatomical, and clinical laboratory analytic scoring systems (Acute Physiology and Chronic Health Evaluation [APACHE], Injury Severity Score [ISS]) are utilized, with limited success, to predict outcome following injury. The recent development of techniques for measuring the expression level of all of a person's genes simultaneously may make it possible to develop an injury scoring system based on the degree of gene activation. We hypothesized that a peripheral blood leukocyte gene expression score could predict outcome, including multiple organ failure, following severe blunt trauma. To test such a scoring system, we measured gene expression of peripheral blood leukocytes from patients within 12 h of traumatic injury. cRNA derived from whole blood leukocytes obtained within 12 h of injury provided gene expression data for the entire genome that were used to create a composite gene expression score for each patient. Total blood leukocytes were chosen because they are active during inflammation, which is reflective of poor outcome. The gene expression score combines the activation levels of all the genes into a single number which compares the patient's gene expression to the average gene expression in uninjured volunteers. Expression profiles from healthy volunteers were averaged to create a reference gene expression profile which was used to compute a difference from reference (DFR) score for each patient. This score described the overall genomic response of patients within the first 12 h following severe blunt trauma. Regression models were used to compare the association of the DFR, APACHE, and ISS scores with outcome. We hypothesized that patients with a total gene response more different from uninjured volunteers would tend to have poorer outcome than those more similar. Our data show that for measures of poor outcome, such as infections, organ failures, and length of hospital stay, this is correct. DFR scores were associated significantly with adverse outcome, including multiple organ failure, duration of ventilation, length of hospital stay, and infection rate. The association remained significant after adjustment for injury severity as measured by APACHE or ISS. A single score representing changes in gene expression in peripheral blood leukocytes within hours of severe blunt injury is associated with adverse clinical outcomes that develop later in the hospital course. Assessment of genome-wide gene expression provides useful clinical information that is different from that provided by currently utilized anatomic or physiologic scores.


  • Open Access

    Passive Immunization to Outer Membrane Proteins MLP and PAL Does Not Protect Mice from Sepsis

    by Catherine H. Valentine, Judith Hellman, Laura K. Beasley-Topliffe, Aranya Bagchi, H. Shaw Warren

    Multiple older studies report that immunoglobulin directed to rough mutant bacteria, such as E. coli J5, provides broad protection against challenge with h


  • Open Access

    Protective Efficacy of CAP18106–138–Immunoglobulin G in Sepsis

    by H. Shaw Warren, Robina Matyal, Jennifer E. Allaire, David Yarmush, Paul Loiselle, Judith Hellman, Barbara G. Paton, Mitchell P. Fink

    Naturally present antibacterial proteins play an important role in innate host defense. A synthetic peptide mimicking the C-terminal lipopolysacchari